Lux Biosciences

[Keymaker]

Has anyone else heard of this company and the 2 products they are working on? They are LX-212 and LX-214. It seems they are only at the end of stage 1 but both look promising.
http://www.luxbio.com/enlargedtext/LX214_et.htm

[ringo]

thank you Keymaker,

let's all hope that all these pipeline medications do not disappear like lots of their predecessors, and make it to the market to bring long-awaited relief to all of us...

[Aaron77]

Voclosporin Ophthalmic Solution As a Candidate for Dry Eye Syndrome

Isotechnika Inc. signed an agreement with Lux Biosciences, Inc. (Lux) of Jersey City, New Jersey granting Lux worldwide rights to develop and commercialize Isotechnika’s lead drug, voclosporin, referred to as LX211 by Lux, for the treatment and prophylaxis of all ophthalmic diseases.

Isotechnika Inc. is right here in my own neighboorhood too. May have to contact them to get a little more info.

http://www.newswire.ca/en/releases/a.../17/c9028.html

- much higher drug levels in target tissues in the eye,
- the lack of irritation, and
- 24-hour therapeutic drug levels in the eye providing a rationale for
once-a-day dosing.

[dave25]

That's pretty cool, I actually go to the University of Missouri - St. Louis and we are an affiliate of the University of Missouri - Kansas City. I'm actually a pre-med student so I will ask some of my biology teachers and see if they know anything about this. Good find.

[Keymaker]

The LX-212 is really amazing. I believe I read that it was being prepared primarily for treatment of MGD. So these are products for both dry eye problems. Hopefully they appear to be an aggressive company and maybe this will work.